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Large, Ca-activated K channels (BK) are comprised of an
a pore (BKa) and one of four b subunits (BKb1–4). When
the gene for BKb1 is knocked out (BKb1-KO), the result is
increased myogenic tone of vascular smooth muscle and
hypertension. We reexamined whether the hypertension is
entirely due to increased vascular tone, because most
monogenic forms of hypertension have renal origins and
BKb1 resides in renal connecting tubule (CNT) cells.
Moreover, BKb1 is localized in the adrenal glands, where it
may control production of aldosterone. This review will
summarize our report that a majority of the hypertension
of BKb1-KO is the result of insufficient handling of dietary K,
resulting in increased plasma K and hyperaldosteronism, the
latter promoting Na and fluid retention. The fluid retention
and hypertension are exacerbated by a high-K diet and
reduced by eplerenone, an aldosterone receptor inhibitor.
Genetic knockout of BKb4 (BKb4-KO), which resides in
intercalated cells, also exhibits deficient K excretion, fluid
retention, and mild hypertension that is not exacerbated
when animals are treated with a high-K diet. These results
show that the hypertension associated with BKb1-KO occurs
because of enhanced fluid retention, as well as because of
the previously described vascular dysfunction.
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BK CHANNELS AND A NEW FORM OF HYPERTENSION
Large, Ca-activated K channels (BK) are ubiquitously
expressed in nearly all mammalian cells. The BK pore-
forming proteins (BKa) are tailored to the functional needs
of cells by their differing splice variants and by associating
with one of four different accessory subunits (BKb1–4). Each
subunit bestows different pharmacological and biophysical
properties to BK. For example, BKb1 enhances the Ca and
voltage sensitivity of BKa.1 The role of the BKb1 subunit in
the modulation of blood pressure was first shown by Brenner
et al.2 who reported that the mean arterial pressure (MAP) of
mice null for BKb1 (BKb1-knockout (KO)) was elevated
by 21 mm Hg. Subsequently, several additional studies have
shown that the BKb1 gene (Kcnmb1) is involved in the
manifestation of a hypertensive phenotype.3–8
It has been previously published that vascular smooth
muscle tone is increased in BKb1-KO. This increase is
thought to be because, in the absence of BKb1, the BKa pore
is less sensitive to Ca sparks. Normally, BKa/b1 channels
open in response to Ca sparks, leading to a compensatory
vasorelaxation. However, in BKb1-KO, BK channel activity
becomes uncoupled from Ca sparks, thereby leading to
hypertension.2–4,9 Although sympathetic increases in vascular
tone contribute to hypertension,10 almost all known forms
of monogenic hypertension are of renal origin.11 Therefore,
we have recently reexamined the hypertensive phenotype of
BKb1-KO in greater detail. In concert with previous studies,
we found an elevated MAP of 137 mm Hg in BKb1-KO versus
116 mm Hg in wild-type mice (WT) of the C57Bl/6 strain.
However, we also observed a unique feature of this
hypertension: it is exacerbated by high dietary K to a mean
MAP of 145 mm Hg. This review will discuss the details of
these findings: how a dual effect of the absence of BKb1 in
the connecting tubule and the adrenal medulla causes
K retention concomitant with primary aldosteronism and a
positive Na balance. In addition, we will discuss the role of
the BKb4 subunit in electrolyte handling in the distal
nephron. On the basis of these findings, we will speculate
on the potential relevance of BKb1-KO hypertension in
humans.
RENAL LOCALIZATIONS OF BKb1 AND BKb4 AND THEIR
ROLES IN K SECRETION
BKb1 has been considered to be uniquely associated with
BKa in all types of smooth muscle,12–14 as well as in renal
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mesangial cells,15,16 which have contractile properties similar
to those of smooth muscle. It was therefore surprising to
observe BKb1 in the apical membrane of the mouse and
rabbit renal connecting tubule (CNT),17,18 an important site
of K secretion along the nephron. A K secretory role for
BKb1 in the CNT was first indicated by an attenuated
kaliuretic response of BKb1-KO when volume expanded
significantly with a physiological saline solution.17 This result
was consistent with the failure of the CNT of BKb1-KO to
secrete K in response to either Na delivery or high distal flow,
both of which can stimulate K secretion in this segment by
supplying a chemical driving force and stimulating the
activation of BKa/b1.19,20 The CNT, also known as the late
distal tubule, is the nephron site at which flow-induced
K secretion was initially discovered with in vivo micro-
puncture techniques.21,22 Although exclusively localized to
the CNT in mouse, the BKb1 was also identified in the initial
part of the cortical collecting duct (CCD) in rabbit.17
It has been generally accepted that basal K secretion is
mediated by renal outer medullary K channel Kir1.1, whereas
flow-induced K secretion is mediated by BK.23 Stimulation
of K secretion by high flow or increased Na delivery is
important clinically, as a reduction in plasma K concentra-
tion is a common complication for patients treated with loop
or thiazide diuretics. In addition, flow-induced K secretion is
physiologically relevant for animals on a high-K diet. When
fed a high-K diet for several days, K secretion is initially
stimulated by aldosterone, which increases the driving force
for K secretion by enhancing apical epithelial Na channel
(EnaC) and basolateral Na–K–ATPase. However, because of
water reabsorption, K secretion is limited by a rapid buildup
of K concentration in the lumen of the CCD, reversing
the chemical gradient in the direction of K reabsorption in
the medullary collecting duct.24 The reabsorbed K recycles
(secretes) into the descending limb of Henle’s loop causing
filtrate K concentration to be very high.25–27 The medullary
interstitial K concentration is high enough (ranging from
35 to 50 mM4) to depolarize the basolateral membrane of the
thick ascending limb to the extent that the driving force for
transcellular Cl reabsorption is reduced. The elevated
intracellular Cl concentration decreases the passive gradient
for Na reabsorption through the apical Na–K–2Cl cotran-
sporter, thereby markedly reducing Na reabsorption in the
thick ascending limb and causing a large increase in Na
delivery and flow down the distal nephron. Consuming a
high-K diet for several days enhances flow by more than
fourfold in mice28,29 and twofold in rats.30 Increased Na is
delivered to the CNT and CCD to exchange for K. Moreover,
a cell can now secrete K into a fourfold elevation of luminal
volume, thereby increasing the cell to lumen K gradient by
fourfold. This also suggests that flow-mediated K secretion
and the better known aldosterone-induced mechanism of
K secretion are interdependent: aldosterone directly enhances
medullary K recycling31 and initiates the high lumen to
plasma K gradient necessary for medullary K recycling.
However, aldosterone alone will not effectively eliminate
K without the increased filtrate delivery that is necessary to
reestablish the plasma to lumen chemical gradients and
stimulate the opening of BK.
Eplerenone is an aldosterone receptor blocker, similar to
spironolactone. Our data indicated that the loss of K
secretion in high K-treated BKb1-KO was primarily an
eplerenone-sensitive component. This is consistent with
reports that the CNT has severalfold more Na–K–ATPase32
and 10-fold more aldosterone-regulated ENaC channels than
does any other segment of the nephron.33 The driving force
for K secretion is potent in this segment, with a transepithe-
lial membrane potential of 75 mV in K-adapted rats.34
Thus, the CNT is best equipped to couple K extrusion in
exchange for aldosterone-stimulated Na reabsorption.
The mechanism for aldosterone-mediated K secretion
through BKa/b1 may be partly due to the fact that the large
depolarization of the apical membrane both activates
the channel and increases the driving force for cell to lumen
K exit.
Despite the favorable electrochemical gradient for K
secretion, BKa/b1 is predominantly closed at the resting
membrane potential. However, the channel can open in
response to increased flow. Several studies have shown that
flow increases Ca, at least transiently, in both intercalated
cells (ICs) and principal cells in the CCD.20,35 Therefore, a
part of the mechanism for flow-mediated activation of BK
may be that shear stress induces increased cytosolic Ca, which
stimulates BKa/b1, which is consistent with the role of BKb1
in conferring more Ca/voltage sensitivity to BKa.1 The
combination of aldosterone (which would depolarize the
apical membrane) and elevated intracellular Ca concentra-
tion has the potential to significantly increase the open
probability (Po) of BK channels in the apical membrane.
Therefore, any defect in K handling by BKb1-KO could
involve either a defective response to the depolarization of
the apical membrane or a failure to respond to the flow-
generated increase in intracellular Ca concentration. Both
could be directly or indirectly dependent on aldosterone.
High flow serves to activate BK and replenish chemical
gradients, and the aldosterone-induced increase in Na–K–AT-
Pase activity is necessary to continually supply the cell with
K from the plasma. However, it has been shown that the
aldosterone-induced ENaC and Na–K–ATPase-mediated force
are not the only drivers of K secretion for mammals on a
high-K diet. Our study showed that eplerenone eliminated
only approximately 50% of the elevated K secretion.
However, when high K-treated rats are given amiloride, an
ENaC blocker, they still exhibit a substantial amount of
elevated K secretion.30 With amiloride treatment, the ENaC/
Na% ATP (Na-dependent) driving force for K secretion
should be inhibited. Although it is clear that BKa/b1 is a
component of aldosterone-mediated K secretion, it is not
known whether BKa/b1 is involved in Na-independent K
secretion.
BKb4-KO also has a K secretory defect that results in Na
and fluid retention when placed on a high-K diet.28 It is more
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difficult to understand the role of BKa/b4 in K secretion
because it is localized in ICs, which contain minimal
basolateral Na-K-ATPase and, unlike principal cells, the
Na-K-ATPase in IC does not increase with a high-K diet.
Serial section analysis of immunoidentified ICs from the
connecting tubules and cortical collecting ducts revealed a
reduction in IC size when flow rates in the distal nephron
were elevated by feeding mice a high-K diet. In the absence of
BKb4 (BKb4-KO), ICs were significantly larger and pro-
truded into the lumen. This evidence was consistent with the
notion that the shear stress of the high distal flow in high
K-fed WT mice normally causes a reduction in IC size by
activating BKa/b4, which results in an efflux of intracellular
K. It is not completely understood whether the failure of high
K-fed BKb4-KO mice to exhibit a reduction in IC size cell
size indirectly affects the Na and K transport of the CNT and
CCD or whether BKa/b4 secretes K with an active source of
K delivery other than the Na-K-ATPase. In either case, the
BKa/b4 in IC is necessary to maintain K balance when
animals are presented with a high-K diet.
ALDOSTERONISM IN BKb1-KO
As shown in Figure 1,36 BKb1-KO mice on a regular diet were
retaining fluid as indicated by the significantly lower
hematocrit (45.8% in WT mice and 41.9% in BKb1-KO
mice). The fluid retention and volume expansion of BKb1-
KO on a regular diet were enough to be detected by a lower
hematocrit, but not enough to yield a significant gain of
weight (Figure 1b). The fluid retention and hypertension
were magnified in BKb1-KO mice on a high-K diet as the
hematocrit decreased to 37.4% and the mice gained over 3 g
of weight. The excess fluid, too much to be retained in only
the vascular spaces, was observed in the abdominal cavities of
high K-treated BKb1-KO mice. With eplerenone treatment,
the hematocrits of WT and BKb1-KO mice on high-K diets
increased to 49.7 and 50.2%, respectively, indicating that
eplerenone was causing slight volume depletion in both
genotypes and was probably maximally effective. Eplerenone
treatment reversed most of the hypertension of BKb1-KO,
without affecting MAP in WT animals. The fact that the
edema and most of the hypertension of BKb1-KO were
corrected by eplerenone implicated hyperaldosteronism.
When WT mice were placed on a high-K diet, the plasma
aldosterone concentration increased by 34%, whereas the
plasma K concentration increased by only 0.3 mM. This
compares well with an in vitro study showing that an increase
in plasma K concentration from 4.1 to 5.1 mM caused the
steepest increase, with a doubling of aldosterone production
from the isolated rat adrenal glomerulosa.37
The significantly elevated plasma K concentration in
BKb1-KO mice, compared with WT mice, indicated a
primary defect in renal K secretion. However, part of the
BK-associated hypertension may be the result of increased
sensitivity of the adrenal glomerulosa cells to plasma K,
causing an additional elevation of aldosterone. When
compared with WT, the slope of the plot of aldosterone
produced versus plasma K concentration for BKb1-KO was
increased by nearly twofold to 100%. However, surprisingly,
we discovered that the BKb1 was restricted to the adrenal
medulla. It is not yet understood how an absence of BKb1 in
the adrenal medulla could cause enhanced aldosterone
production in response to an increase in plasma K con-
centration. However, the glomerulosa cells of the cortex and
the chromaffin cells of the adrenal medulla have paracrine
effects on each other.38–41
Aldosteronism was not profound in BKb1-KO mice on a
high-K diet, probably because the atrial natriuretic factor,
which is stimulated by volume expansion, attenuates the
aldosterone response.42,43 Other investigators found that for
BKa knockouts (BKa-KO) on a high-K diet, the plasma
aldosterone concentration was elevated to a greater extent, by
approximately fourfold.29 The more extreme aldosteronism
of BKa-KO may reflect the fact that BKa alone is still a
functional channel in BKb1-KO in the control of aldosterone
release.
A surprising finding in our study was the significant
elevation of the plasma Na concentration by 4 mM (and the
plasma osmolality by 6 mOsm) on a normal diet, compared
with WT controls. This is counter to the notion that
antidiuretic hormone preserves osmolality despite increased
renal Na reabsorption. However, it was revealed several years
ago that there is a ‘resetting’ of the osmostat in states of
primary hyperaldosteronism.44 The mechanism for osmostat
resetting in the face of chronically elevated plasma aldoster-
one has not been established.
ORIGIN OF BK HYPERTENSION—RENAL VERSUS VASCULAR
Eplerenone reduced the hypertension of both regular diet and
high K BKb1-KO to a value approximately 7 mm Hg above
MAP of WT. Thus, enhanced vascular tone, independent of














































Figure 1 |Compromised extracellular volume regulation in
BKb1-KO. Volume status was determined by hematocrits (a) and
weight change (b) of Ca-activated K channel knockout (BKb1-KO)
and wild type (WT) on either control (normal K: 0.32% Na and
0.6% K) or high K (0.32% Na and 5.0% K) diets. *Denotes
significant difference (Po0.05) compared with using the unpaired
t-test. 8Denotes significant difference compared with normal K
(control) using analysis of variance plus the Student–Newman–
Keuls test. zDenotes significant difference compared with high K
using analysis of variance plus the Student–Newman–Keuls test.
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in BKb1-KO. This is consistent both with the findings of
increased myogenic tone in cerebral arteries of BKb1-KO45
and with the view that persistent and significant long-term
monogenic hypertension has a renal origin.11
Figure 2 shows how dietary K and Na contents affect MAP
in BKb1-KO (A) and BKb4-KO (B), relative to WT. For
BKb1-KO, the dependency of MAP on dietary K content is
dramatic. Eplerenone-treated BKb1-KO on a high-K diet and
BKb1-KO on a low-Na diet exhibited MAPs of 8 and
6 mm Hg, respectively, above WT. These results are consistent
with the notion that the vascular smooth muscle tone is
responsible for about 30% of the hypertension, and the fluid
retention from the renal/adrenal defect is responsible for 70%
of the hypertension, in BKb1-KO mice. BKb4-KO mice also
retain Na and fluid but exhibit a milder hypertension than do
BKb1-KO mice. Moreover, BKb4-KO mice did not exhibit a
significant increase in MAP when placed on a high-K diet.
These experiments suggest that BKb1 has a more critical role
than BKb4 with respect to blood pressure regulation.
Table 1 shows the MAP reported by different studies of
BKa-KO and BKb1-KO. As expected, anesthetized mice
exhibited lower MAPs. One study reported an MAP for BKa-
KO that was 19 mm Hg greater than that for WT. Although
these mice were anesthetized, this value was in agreement
with the average (16.5 mm Hg) of four different studies
that determined the difference in MAP between BKb1-KO
and WT.
PERSPECTIVES ON A HUMAN CORRELATION
The important question is whether human polymorphisms
in KCNMB1 are associated with hypertension. If so, can the
hypertension be attenuated by mineralocorticoid receptor
antagonists (spironolactone or eplerenone) or dietary K
restriction. A high-K diet is considered beneficial in the
prevention of stroke and heart disease.46,47 In fact, a high-Na,
low-K diet has been blamed for the high incidence of
cardiovascular disease in western cultures. A high-K diet
increases urinary flow by more than fourfold, causing
the elimination of Na and lowering blood volume while
maintaining a normal concentration of plasma K. The
natural diuretic effect of a K-rich diet could be beneficial
for preventing stroke and cardiovascular disease.
However, a small percentage of the population may have
KCNMB1 polymorphisms that contribute to hypertension.
These individuals would seem to have resistant essential
hypertension. The use of first-line pharmacological agents
such angiotensin-converting enzyme inhibitors or angioten-
sin II receptor antagonist would be ineffective because renin
levels would be low in these individuals. Reducing Na intake
may lower MAP because it would reduce fluid retention.
However, in most instances, the reduction of dietary Na
occurs with an increase in K intake, which would likely
counter any benefit of Na restriction. The plasma K and
aldosterone concentrations would be elevated but potentially
remain within the range of what is considered normal. The
most notable phenotype of such individuals would be the
near normalization of MAP following mineralocorticoid
receptor antagonism. Such a subset of essential hypertensive
subjects are known to have primary hyperaldosteronism
with normal plasma K, and are responsive to aldosterone
receptor blockers.48 It would be interesting to determine
whether these individuals have loss-of-function polymorph-
isms in KCNMB1.
Although a loss-of-function polymorphism has not yet
been identified, several groups have confirmed a BKb1 gain-
of-function mutation caused by a single-nucleotide poly-
morphism resulting in an amino-acid substitution (E65K).
This mutation is associated with lower blood pressure levels
in a variety of population samples.5,7,48–51 The E65K
mutation enhances the gain of the hyperpolarizing feedback
mechanism by more effectively coupling BKa to Ca sparks,
thereby reducing vascular tone. It is unclear whether the
protection from hypertension of E65K5,7 would be related to






















































Figure 2 | Effect of K diet on MAP of BKb1-KO and BKb4-KO.
(a) MAPs of BKb1-KO versus wild type (WT). (b) BKb4-KO versus
WT. Low K contains 0.32% Na and 0.1% K. All other symbols are
the same as in Figure 1.












BKa-KO SV129/C57Bl6 Catheter (anesthetized) 94±4 75±7 19 Rieg et al.29
BKb1-KO SV129 Catheter (conscious) 134±5 114±6 20 Brenner et al.2
BKb1-KO SV129/C57Bl6 Catheter (conscious) 118±3 104±2 14 Pluger et al.3
BKb1-KO C57Bl6 Catheter (anesthetized) 104±3 93±2 11 Pluznick et al.15
BKb1-KO C57Bl6 Tail-cuff (conscious) 137±3 116±3 21 Grimm et al.18
Abbreviations: BK, Ca-activated K channel; BP, blood pressure; KO, knockout; MAP, mean arterial pressure; WT, wild type.
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However, the gain in function would render the vessels more
compliant to increases in renal retention of Na and fluid. It
would be interesting to determine whether the E65K
mutation, specifically incorporated into the CNT, causes
BKb1-KO to handle a high-K load more efficiently than WT.
It may seem that K secretion by BKa/b1 is irrelevant,
considering that the modern diet consists of high Na and low
K and that BKa/b1 may have been more used by the ‘hunter
and gatherer’ populations.52 However, it is possible that the
consumption of a low-K diet for several thousands of years
has permitted mutations in BKb1. A sudden change to a
vegetarian (high potassium) diet may lead to noticeable
hypertension in a small subset of subjects.
Although a loss-of-function KCNMB1 polymorphism that
influenced blood pressure would likely be rare, a large
segment of the population could be affected by several
conditions that cause a loss of relative expression of BKb1 in
tissues. BKb1-related changes in K handling and fluid balance
might be manifested more profoundly in the elderly, because
the expression levels of both BKa and BKb1 decrease with
aging.7,53 Decreased expression and functionality of BKa/b1
could partially explain the difficulty that many elderly
patients face in controlling their blood pressure and
electrolyte concentrations. Evidence suggests that a decrease
in perfusion of the retinal arterioles in subjects with type 1
diabetes mellitus is the result of a downregulation of BKb1,
resulting in increased arteriole myogenic tone.54 If BKb1 is
similarly decreased in the CNT of diabetic patients, then the
ensuing fluid retention would exacerbate the retinopathy and
may be partly responsible for the hypertension.
Although the significance of BKb1-related hypertension to
the human population remains to be fully explored, we have
learned that the inability of renal K channels in the CNT to
excrete a K load will result in a mild form of potassium-
sensitive hypertension. As in all other forms of monogenic
hypertension, the renal–adrenal axis has a major role.
However, the hypertensive effect of fluid retention is
magnified by increased vascular smooth muscle tone.
SUMMARY
The BKb1-KO mouse has a hypertensive phenotype that is
30% due to intrinsic tone and 70% due to Na and volume
retention. The percentage of hypertension due to fluid
retention increases when BKb1-KO mice are placed on a
high-K diet. Figure 3 illustrates how the defect in
BK-mediated K secretion in the connecting tubule leads to
Na and volume retention and hypertension in BKb1-KO
mice. The latter is the result of deficient K excretion by
BKa/b1 in the CNT, resulting in an elevated plasma K
concentration that stimulates aldosterone production in the
adrenal glomerulosa. The aldosteronism may be amplified in
an undetermined way by a lack of BKb1 in the adrenal
medulla. The combination of deficient K secretion and a
hypersensitive adrenal gland results in the unusual combina-
tion of chronic primary aldosteronism with normal to high
plasma K. Although a high-K diet is beneficial to the majority
of the population, there may be a small subset of patients
who have a KCNMB1 polymorphism with a phenotype of
elevated MAP because of fluid retention exaggerated by a
high-K diet. It may be difficult to identify single-nucleotide
polymorphisms in this group of individuals because of the
multitude of genetic and environmental contributors to
hypertension. Nevertheless, identification of subjects with
loss-of-function mutations of KCNMB1 may allow for more
appropriate antihypertensive treatment regimens for these
individuals. The effects of aging and diabetes on the
expression of BK and potential consequences of reduced
BKb1 on fluid balance should be explored.
More studies are necessary to examine the K secretory role
of the IC-localized BKb4. Although BKb4-KO also retains
fluid on a high-K diet, these mice have much milder
hypertension. This is further evidence that the increased
intrinsic vascular tone, although accounting for only
6–8 mm Hg, is necessary for the high MAP exhibited by the
high K diet-fed BKb1-KO mice. Transgenics with renal,
adrenal, and vascular smooth muscle cell-specific deletions
and insertions of BKa and its differing accessory components
will address many future questions regarding the hyperten-
sion of BKa-KO and BKb1-KO.
DISCLOSURE



























Figure 3 | Illustration of how high K-fed Ca-activated K
channel knockout (BKb1-KO) mice can develop Na, Cl, and
fluid retention. On high dietary K intake, the absence of BKb1 in
the connecting tubule (CNT) results in relative basolateral K
recycling instead of its secretory role. The elevated K stimulates
aldosterone (Aldo) production from the adrenals, which have
enhanced sensitivity to K in BKb1-KO. The increased plasma
aldosterone stimulates Na and Cl reabsorption instead of an
exchange of K for Na.
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